PHIA Koninklijke Philips N.V.

Philips, World Bank, and Ukraine Ministry of Health announce successful deployment of nationwide acute stroke care upgrade, helping thousands of patients

Philips, World Bank, and Ukraine Ministry of Health announce successful deployment of nationwide acute stroke care upgrade, helping thousands of patients

February 10, 2025

Groundbreaking program that provides technology and training is reducing the impact of stroke, one of the leading causes of death and disability, by establishing an advanced nationwide acute stroke  treatment network

Amsterdam, the Netherlands and Kyiv, Ukraine – (NYSE: PHG, AEX: PHIA), a global leader in health technology, in collaboration with the World Bank and Ukraine’s Ministry of Health (MOH), today announced a nationwide initiative to modernize stroke and cardiovascular care in Ukraine. The demand for stroke care in Ukraine is nearly doubling, exacerbated by war damage and displaced populations lacking access to timely care. This program – which is already well on its way – aims to address these immense challenges by creating an advanced network of locations for the diagnosis and treatment of stroke.

The joint initiative delivers advanced image-guided therapy systems optimized for acute stroke treatment to key regions, including Dnipro, Sumy, Kharkiv, Lviv, Zaporizhzha and Odesa. Philips is deploying 25 of its Azurion interventional suites to support minimally invasive stroke treatments. These systems support complex neurovascular procedures, such as thrombectomies*, which can reverse stroke effects. The systems integrate software tools and technologies to accelerate procedures and enhance care coordination. Together, these innovations streamline care pathways, reduce treatment delays and improve patient outcomes. Philips is working with its partner, AFS Medizintechnik, to roll out systems across the country. So far, 19 systems have been installed and are already helping Ukrainian physicians provide optimized care to their stroke patients.

“Every year, approximately 140,000 Ukrainians experience a stroke, with many facing disability or death due to delayed treatment,” said Carla Goulart Peron, Chief Medical Officer at Philips. “This collaboration ensures patients in underserved regions gain access to life-saving technologies.”

“This program is saving lives, reducing disability, and changing the futures of stroke patients,” said Dr. Dmytro Lebedynets, a neurologist at Feofaniya Clinical Hospital and consultant on stroke to the World Bank and the Ministry of Health of Ukraine. “With these advanced tools, we can deliver timely and precise life-saving care, even in emergencies. It’s a game-changer for our patients. Now all the regions of our country will be able to provide the full spectrum of care to stroke patients.”

Comprehensive training

The program also emphasizes comprehensive clinical training to ensure the new stroke network  is utilized to its full potential. As part of the initiative, physicians will undergo hands-on education and training in Poland. This approach guarantees the latest expertise in stroke treatment , enabling consistent high-quality care delivery across Ukraine.

Partnering with World Stroke Organization

Philips’ ongoing with the World Stroke Organization, established in 2023, has been further expanded through its involvement in the WSO Advocacy Coalition, becoming part of a global network that actively works on healthcare policy, raises public awareness, and advocates for increased investment in stroke care infrastructure.

* A thrombectomy is a minimally invasive procedure where doctors use a small device called a catheter to remove a blood clot from a blood vessel, restoring normal blood flow and preventing damage to vital organs like the brain.

For further information, please contact:

Joost Maltha

Philips Global External Relations

Tel.: 6

E-mail :

About Royal Philips

Royal Philips (NYSE: PHG, AEX: PHIA) is a leading health technology company focused on improving people's health and well-being through meaningful innovation. Philips’ patient- and people-centric innovation leverages advanced technology and deep clinical and consumer insights to deliver personal health solutions for consumers and professional health solutions for healthcare providers and their patients in the hospital and the home. Headquartered in the Netherlands, the company is a leader in diagnostic imaging, ultrasound, image-guided therapy, monitoring and enterprise informatics, as well as in personal health. Philips generated 2023 sales of EUR 18.2 billion and employs approximately 69,300 employees with sales and services in more than 100 countries. News about Philips can be found at .

Attachments



EN
10/02/2025

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Koninklijke Philips N.V.

 PRESS RELEASE

Philips expands digital pathology portfolio with cloud-enabled Philips...

Philips expands digital pathology portfolio with cloud-enabled Philips IntelliSite Pathology Solution on HealthSuite March 11, 2026 Fully cloud‑enabled solution designed to help healthcare organizations scale digital pathology adoption and workflows Amsterdam, The Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced the expansion of its digital pathology portfolio with new cloud-enabled capabilities designed to help healthcare organizations scale digital diagnostics, improve productivity, and advance their transformation to fully digital workflows....

 PRESS RELEASE

Philips connects patient monitoring and diagnostics to advance platfor...

Philips connects patient monitoring and diagnostics to advance platform-based care intelligence at HIMSS26 March 10, 2026 Amsterdam, the Netherlands, and Las Vegas, USA – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today highlighted how open, interoperable, AI-enabled platforms can help health systems connect continuous patient monitoring with diagnostic insights – bringing the patient story together across time and across specialties. By connecting clinical signals with diagnostic information, Philips enables care teams to move from fragmented data to a more continuous,...

Marc Hesselink ... (+2)
  • Marc Hesselink
  • CFA

Philips/Execution is key/HOLD

Philips reported a better-than-expected 4Q25 update and a supportive CMD message. We increase our estimates, raise our target price from €23 to €26 and reiterate our Hold rating. Philips appears positioned to continue progressing operationally, but we believe consistent delivery will be required before we see meaningful outperformance versus the sector. Valuation at 15x adj EPS 2027F is in line with peers.

 PRESS RELEASE

Philips unveils Rembra CT at ECR 2026, setting a new benchmark for spe...

Philips unveils Rembra CT at ECR 2026, setting a new benchmark for speed and patient access designed to support diagnostic confidence for acute and high-demand imaging environments March 4, 2026 CE Marked and 510(k) pending, Rembra’s advanced image reconstruction technology delivers up to 106 images per second [1] and a high throughput of up to 270 patients per day [2] to support faster diagnosis by making scans available in near-real timeWith the largest-in-class 85 cm bore, Rembra accommodates challenging patient types, providing more access for complex interventions, bariatric imaging a...

 PRESS RELEASE

Philips publishes its Annual Report 2025

Philips publishes its Annual Report 2025 February 19, 2026 Amsterdam, the Netherlands – (NYSE: PHG, AEX: PHIA), a global leader in health technology, today published its Annual Report 2025. Philips’ Annual Report 2025 will be on the agenda of the Annual General Meeting of Shareholders (AGM), to be held on May 8, 2026. The convocation notice and the agenda, including explanatory notes, for the AGM will be published in due course. Philips filed the Annual Report 2025 with the Netherlands Authority for the Financial Markets (AFM) in European Single Electronic Format (ESEF) and expects to f...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch